Literature DB >> 3543057

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.

S Mojsov, G C Weir, J F Habener.   

Abstract

Insulin secretion is controlled by a complex set of factors that include not only glucose but amino acids, catecholamines, and intestinal hormones. We report that a novel glucagon-like peptide, co-encoded with glucagon in the glucagon gene is a potent insulinotropic factor. The glucagon gene encodes a proglucagon that contains in its sequence glucagon and additional glucagon-like peptides (GLPs). These GLPs are liberated from proglucagon in both the pancreas and intestines. GLP-I exists in at least two forms: 37 amino acids GLP-I(1-37), and 31 amino acids, GLP-I(7-37). We studied the effects of synthetic GLP-Is on insulin secretion in the isolated perfused rat pancreas. In the presence of 6.6 mM glucose, GLP-I(7-37) is a potent stimulator of insulin secretion at concentrations as low as 5 X 10(-11) M (3- to 10-fold increases over basal). GLP-I(1-37) had no effect on insulin secretion even at concentrations as high as 5 X 10(-7) M. The earlier demonstration of specific liberation of GLP-I(7-37) in the intestine and pancreas, and the magnitude of the insulinotropic effect at such low concentrations, suggest that GLP-I(7-37) participates in the physiological regulation of insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3543057      PMCID: PMC424143          DOI: 10.1172/JCI112855

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide.

Authors:  M Schebalin; S I Said; G M Makhlouf
Journal:  Am J Physiol       Date:  1977-02

2.  Stimulation of insulin secretion by gastric inhibitory polypeptide in man.

Authors:  J Dupre; S A Ross; D Watson; J C Brown
Journal:  J Clin Endocrinol Metab       Date:  1973-11       Impact factor: 5.958

3.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties.

Authors:  J D Albano; R P Ekins; G Maritz; R C Turner
Journal:  Acta Endocrinol (Copenh)       Date:  1972-07

4.  A rat pancreas-small gut preparation for the study of intestinal factor(s) and insulin release.

Authors:  J C Penhos; C H Wu; J C Basabe; N Lopez; F W Wolff
Journal:  Diabetes       Date:  1969-11       Impact factor: 9.461

5.  Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon.

Authors:  E Samols; G Marri; V Marks
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

6.  The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas.

Authors:  R A Pederson; J C Brown
Journal:  Endocrinology       Date:  1976-09       Impact factor: 4.736

7.  Possible roles of the pancreatic D-cell in the normal and diabetic states.

Authors:  R H Unger; L Orci
Journal:  Diabetes       Date:  1977-03       Impact factor: 9.461

8.  Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.

Authors:  C Orskov; J J Holst; S Knuhtsen; F G Baldissera; S S Poulsen; O V Nielsen
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

9.  Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.

Authors:  D K Andersen; D Elahi; J C Brown; J D Tobin; R Andres
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  Glucagon secretion from the perfused rat pancreas. Studies with glucose and catecholamines.

Authors:  G C Weir; S D Knowlton; D B Martin
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

View more
  174 in total

1.  The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties.

Authors:  D M Irwin; M Satkunarajah; Y Wen; P L Brubaker; R A Pederson; M B Wheeler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release.

Authors:  P L Brubaker; S Efendic; G R Greenberg
Journal:  Endocrine       Date:  1997-02       Impact factor: 3.633

3.  Glucagon-like peptide-1 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro.

Authors:  Sara Baldassano; Guo-Du Wang; Flavia Mulè; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-10       Impact factor: 4.052

Review 4.  Enhancing bowel adaptation in short bowel syndrome.

Authors:  Palle Bekker Jeppesen; Per Brobech Mortensen
Journal:  Curr Gastroenterol Rep       Date:  2002-08

5.  Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors.

Authors:  Frédéric Preitner; Mark Ibberson; Isobel Franklin; Christophe Binnert; Mario Pende; Asllan Gjinovci; Tanya Hansotia; Daniel J Drucker; Claes Wollheim; Rémy Burcelin; Bernard Thorens
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

6.  Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms.

Authors:  Jingchuan Zhang; Robert C Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-10-26       Impact factor: 3.619

Review 7.  The structure and function of the glucagon-like peptide-1 receptor and its ligands.

Authors:  Dan Donnelly
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

8.  Hypoglycemic Effects of Intestinal Electrical Stimulation by Enhancing Nutrient-Stimulated Secretion of GLP-1 in Rats.

Authors:  Feng Ye; Yi Liu; Shiying Li; Jiande D Z Chen
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

9.  Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.

Authors:  T Tolessa; M Gutniak; J J Holst; S Efendic; P M Hellström
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

Review 10.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.